Related Experiment Video
Updated: Dec 8, 2025

Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
Published on: August 11, 2017
Identification, isolation and characterization of a new impurity in drug substance resulting from stress stability
Vundavilli Jagadeesh Kumar1, P Badarinadh Gupta1, K Mukkanti2
1Aurobindo Pharma Ltd Research Centre, 313, Bachupally, Qutubullapur Mandal, Hyderabad, 500090, Andhra Pradesh, India. jagadishkumar28@rediffmail.com pavan_kothapalli@rediffmail.com.
Abstract:
A new unknown impurity of cefoxitin formed during a gradient reverse phase high performance liquid chromatography (HPLC) analysis of stress stability samples of the drug substance cefoxitin, and the level of this impurity was found at up to 0.9%. This impurity was identified by LC-MS and characterized by (1H NMR, 13C NMR, LC/MS/MS, elemental analysis and FT-IR). Based on the spectral data, the impurity was named as, 3-[[(2R,3S)-[3-methoxy-3-N-[2-(thiophen-2-yl)acetamido]]-4-oxoazetidin-2-ylthio]-2-[(carbamoyloxy)methyl]]-acrylic acid. The structure of this impurity was also established unambiguously, prepared by isolation and co-injected into HPLC to confirm the retention time. To the best of our knowledge, this impurity has not been reported elsewhere. Structural elucidation of the impurity by spectral data is discussed in detail.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
07:29HPLC Coupled with Chemical Fingerprinting for Multi-Pattern Recognition for Identifying the Authenticity of Clematidis Armandii Caulis
Published on: November 11, 2022
Related Concept Videos
Drug Product Stability
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Clinically Relevant Drug Product Specifications: Methods of Establishment
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
In Vitro Drug Release Testing: Overview, Development and Validation
Drug Dissolution: Requirements and Profile Comparison